Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 164
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Scand J Med Sci Sports ; 27(12): 2048-2058, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28241395

RESUMEN

Contrast-enhanced ultrasound (CEUS) is used to visualize the microvascularization in various tissues. The purpose of this study was to investigate whether CEUS could be used to visualize the microvascular volume (MV) in the plantar fascia, and to compare the method to clinical symptoms and B-mode ultrasound (US) in patients with plantar fasciitis (PF). Twenty patients with unilateral PF were included and were divided by US in insertional thickening (10), midsubstance thickening (5), and no US changes (5). The MV was measured simultaneously in both heels. Four areas in the plantar fascia and plantar fat pad were measured independently by two observers. Inter- and intra-observer correlation analyses were performed. The asymptomatic heels showed a constantly low MV, and for the whole group of patients, a significantly higher MV was found in the symptomatic plantar fascia and plantar fat pad. Inter-observer correlation as well as intra-observer agreement was excellent. The MV in the plantar fascia and plantar fat pad can be measured reliably using CEUS, suggesting that it is a reproducible method to examine patients with plantar fasciitis.


Asunto(s)
Fascitis Plantar/diagnóstico por imagen , Talón/diagnóstico por imagen , Ultrasonografía , Adulto , Fascia/diagnóstico por imagen , Humanos , Persona de Mediana Edad , Variaciones Dependientes del Observador
2.
Int J Obes (Lond) ; 38(2): 259-65, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23736366

RESUMEN

OBJECTIVE: Glucose-dependent insulinotropic polypeptide (GIP) appears to have a role in lipid metabolism. Recently, we showed that GIP in combination with hyperinsulinemia and hyperglycemia increases triglyceride uptake in abdominal, subcutaneous adipose tissue in lean humans. It has been suggested that increased GIP secretion in obesity will promote lipid deposition in adipose tissue. In light of the current attempts to employ GIP antagonists in the treatment and prevention of human obesity, the present experiments were performed in order to elucidate whether the adipose tissue lipid metabolism would be enhanced or blunted during a GIP, hyperinsulinemic and hyperglycemic (HI-HG) clamp in obese subjects with either normal glucose tolerance (NGT) or impaired glucose tolerance (IGT). DESIGN: Sixteen obese (BMI>30 kg m(-2)) subjects were divided into two groups, based on their plasma glucose response to an oral glucose challenge: (i) NGT and (ii) IGT. Abdominal, subcutaneous adipose tissue lipid metabolism was studied by conducting measurements of arteriovenous concentrations of metabolites and regional adipose tissue blood flow (ATBF) during GIP (1.5 pmol kg(-1) min(-1)) in combination with a HI-HG clamp. RESULTS: In both groups, ATBF responses were significantly lower than what we have found previously in healthy, lean subjects (P<0.0001). The flow response was significantly lower in the IGT group than in the NGT group (P=0.03). It was not possible to show any increase in the lipid deposition in adipose tissue under the applied experimental conditions and likewise the circulating triglyceride (TAG) concentrations remained constant. CONCLUSION: The applied GIP, HI-HG clamp did not induce any changes in TAG uptake in adipose tissue in obese subjects. This may be due to a blunted increase in ATBF. These experiments therefore suggest that GIP does not have a major role in postprandial lipid metabolism in obese subjects.


Asunto(s)
Polipéptido Inhibidor Gástrico/metabolismo , Hiperglucemia/metabolismo , Hiperinsulinismo/metabolismo , Resistencia a la Insulina , Obesidad/metabolismo , Grasa Subcutánea Abdominal/metabolismo , Adulto , Glucemia/metabolismo , Técnica de Clampeo de la Glucosa , Intolerancia a la Glucosa/metabolismo , Prueba de Tolerancia a la Glucosa , Humanos , Masculino , Receptores de la Hormona Gastrointestinal/metabolismo , Flujo Sanguíneo Regional , Grasa Subcutánea Abdominal/irrigación sanguínea , Triglicéridos/metabolismo
3.
Euro Surveill ; 19(40): 20920, 2014 Oct 09.
Artículo en Inglés | MEDLINE | ID: mdl-25323076

RESUMEN

We analyse up-to-date epidemiological data of the Ebola virus disease outbreak in Nigeria as of 1 October 2014 in order to estimate the case fatality rate, the proportion of healthcare workers infected and the transmission tree. We also model the impact of control interventions on the size of the epidemic. Results indicate that Nigeria's quick and forceful implementation of control interventions was determinant in controlling the outbreak rapidly and avoiding a far worse scenario in this country.


Asunto(s)
Trazado de Contacto , Brotes de Enfermedades/prevención & control , Ebolavirus/aislamiento & purificación , Fiebre Hemorrágica Ebola/epidemiología , Fiebre Hemorrágica Ebola/transmisión , Modelos Teóricos , Fiebre Hemorrágica Ebola/prevención & control , Humanos , Nigeria/epidemiología , Práctica de Salud Pública , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Procesos Estocásticos , Viaje
4.
Int J Obes (Lond) ; 37(5): 748-50, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-22751255

RESUMEN

The aim of this study was to investigate subcutaneous adipose tissue lymphatic drainage (ATLD) of macromolecules in lean and obese subjects and, furthermore, to evaluate whether ATLD may change in parallel with adipose tissue blood flow. Lean and obese male subjects were studied before and after an oral glucose load. Adipose-tissue blood flow was measured in the anterior subcutaneous abdominal adipose tissue by the (133)Xe-washout technique. ATLD was measured as the disappearance rate of (99m)Tc-labelled nanoaggregated human albumin, during fasting and after an oral glucose load. A significant increase in ATLD was seen after the glucose load in the lean subjects. In the obese subjects, ATLD remained constant throughout the study and was significantly lower compared to the lean subjects. These results indicate a reduced ability to remove macromolecules from the interstitial space through the lymphatic system in obese subjects. Furthermore, they suggest that postprandial changes in ATLD taking place in lean subjects are not observed in obese subjects. This may have a role in the development of obesity-related inflammation in hypertrophic adipose tissue.


Asunto(s)
Tejido Adiposo/fisiopatología , Vasos Linfáticos/fisiopatología , Sustancias Macromoleculares/metabolismo , Obesidad/fisiopatología , Paniculitis/fisiopatología , Adulto , Ayuno , Glucosa/metabolismo , Humanos , Inflamación/metabolismo , Inflamación/fisiopatología , Masculino , Obesidad/complicaciones , Obesidad/metabolismo , Paniculitis/etiología , Paniculitis/metabolismo , Periodo Posprandial , Flujo Sanguíneo Regional , Grasa Subcutánea Abdominal/fisiopatología , Delgadez/metabolismo , Delgadez/fisiopatología
5.
Br J Anaesth ; 109(2): 191-9, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22710266

RESUMEN

BACKGROUND: We aimed to investigate whether fluid therapy with a goal of near-maximal stroke volume (SV) guided by oesophageal Doppler (ED) monitoring result in a better outcome than that with a goal of maintaining bodyweight (BW) and zero fluid balance in patients undergoing colorectal surgery. METHODS: In a double-blinded clinical multicentre trial, 150 patients undergoing elective colorectal surgery were randomized to receive fluid therapy after either the goal of near-maximal SV guided by ED (Doppler, D group) or the goal of zero balance and normal BW (Zero balance, Z group). Stratification for laparoscopic and open surgery was performed. The postoperative fluid therapy was similar in the two groups. The primary endpoint was postoperative complications defined and divided into subgroups by protocol. Analysis was performed by intention-to-treat. The follow-up was 30 days. The trial had 85% power to show a difference between the groups. RESULTS: The number of patients undergoing laparoscopic or open surgery and the patient characteristics were similar between the groups. No significant differences between the groups were found for overall, major, minor, cardiopulmonary, or tissue-healing complications (P-values: 0.79; 0.62; 0.97; 0.48; and 0.48, respectively). One patient died in each group. No significant difference was found for the length of hospital stay [median (range) Z: 5.00 (1-61) vs D: 5.00 (2-41); P=0.206]. CONCLUSIONS: Goal-directed fluid therapy to near-maximal SV guided by ED adds no extra value to the fluid therapy using zero balance and normal BW in patients undergoing elective colorectal surgery.


Asunto(s)
Fluidoterapia/métodos , Intestino Grueso/cirugía , Cuidados Intraoperatorios/métodos , Volumen Sistólico/fisiología , Equilibrio Hidroelectrolítico/fisiología , Anciano , Anciano de 80 o más Años , Método Doble Ciego , Ecocardiografía Transesofágica/métodos , Femenino , Objetivos , Humanos , Masculino , Persona de Mediana Edad , Monitoreo Intraoperatorio/métodos , Complicaciones Posoperatorias , Resultado del Tratamiento , Ultrasonografía Intervencional/métodos
6.
Scand J Med Sci Sports ; 22(3): 399-409, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22612362

RESUMEN

There is a pronounced gender difference in the accumulation of plasma ammonia after sprint exercise. Ammonia is a key intermediate in amino acid metabolism, which implies that gender-related differences in plasma and muscle amino acid concentrations after sprint exercise exist. To study this, three bouts of 30-s sprint exercise were performed by healthy females (n=8) and males (n=6). Blood leucine and muscle leucine were collected over the exercise period. Basal arterial plasma and skeletal muscle leucine were 40% higher in males than females (P<0.010 and P<0.020). Plasma, but not muscle, leucine decreased by sprint exercise and more so in males than females (g × t: P=0.025). Increase in ammonia was higher in males than females in both plasma and muscle (g × t: P<0.001 and P=0.003). An opposite pattern was shown for plasma glutamine, where an increase was found in females (P<0.001), but not in males. In conclusion, the lower plasma ammonia after sprint exercise in females seems to be explained by a lower accumulation of ammonia in skeletal muscle and by a buffering of ammonia in the form of glutamine in females. The greater reduction in plasma leucine in males seems to be related to their greater increase in muscle ammonia after sprint exercise.


Asunto(s)
Ciclismo/fisiología , Leucina/sangre , Adulto , Análisis de Varianza , Biopsia , Regulación hacia Abajo , Femenino , Humanos , Masculino , Músculo Esquelético/fisiología , Factores Sexuales , Encuestas y Cuestionarios
7.
Diabetes Obes Metab ; 11(9): 884-90, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19508463

RESUMEN

AIM: The glucagon-like peptide-1 (GLP-1) receptor agonist, exendin-4, has previously been shown to delay the onset of diabetes when administered to Goto-Kakizaki (GK) rats in the prediabetic period. The present study aimed to evaluate whether long-term administration of exendin-4 to GK rats in the diabetic period would improve their diabetes and how glycaemic control was affected following drug wash-out. METHODS: Glycaemic control was assessed in diabetic GK rats during 12 weeks of exendin-4 or vehicle treatment. Moreover, some animals were followed for an additional 9 weeks without treatment. RESULTS: Glycaemic control was seen to deteriorate in vehicle-treated animals, as assessed by increased glycated haemoglobin A1c (HbA1c), whereas HbA1c improved in exendin-4-treated animals. Following an additional 9 weeks without treatment, glycaemic control in exendin-4-treated animals remained below baseline value and thus remained significantly lower than that of vehicle-treated animals. Following exendin-4 administration, oral glucose tolerance tests revealed greatly reduced glucose and insulin excursions compared with vehicle-treated animals, whereas following overnight drug wash-out, only little difference was seen, suggesting that the improvement in glycaemic control may have been obtained primarily by increased postprandial control. No significant differences were observed in pancreatic islet morphology or islet hormone content. CONCLUSIONS: Exendin-4 treatment improved glycaemic control in diabetic GK rats, independent of changes in beta-cell mass. Additionally, progression of the disease seemed to be delayed because the improvement in HbA1c was still apparent 9 weeks after cessation of treatment.


Asunto(s)
Hipoglucemiantes/uso terapéutico , Péptidos/uso terapéutico , Receptores de Glucagón/antagonistas & inhibidores , Ponzoñas/uso terapéutico , Animales , Área Bajo la Curva , Glucemia/análisis , Glucemia/metabolismo , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus Tipo 2/fisiopatología , Modelos Animales de Enfermedad , Exenatida , Receptor del Péptido 1 Similar al Glucagón , Hemoglobina Glucada/metabolismo , Insulina/sangre , Páncreas/patología , Ratas , Ratas Mutantes , Ratas Wistar
8.
Obes Rev ; 18(10): 1159-1169, 2017 10.
Artículo en Inglés | MEDLINE | ID: mdl-28660651

RESUMEN

Chronic lymphoedema is a disease caused by a congenital or acquired damage to the lymphatic system and characterized by complex chains of pathophysiologic events such as lymphatic fluid stasis, chronic inflammation, lymphatic vessels impairment, adipose tissue deposition and fibrosis. These events seem to maintain and reinforce themselves through a positive feedback loop: regardless of the initial cause of lymphatic stasis, the dysfunctional adipose tissue and its secretion products can worsen lymphatic vessels' function, aggravating lymph leakage and stagnation, which can promote further adipose tissue deposition and fibrosis, similar to what may happen in obesity. In addition to the current knowledge about the tight and ancestral interrelation between immunity system and metabolism, there is evidence for similarities between obesity-related and lymphatic damage-induced lymphoedema. Together, these observations indicate strong reciprocal relationship between lymphatics and adipose tissue and suggest a possible key role of the adipocyte in the pathophysiology of chronic lymphoedema's vicious circle.


Asunto(s)
Adipocitos/fisiología , Linfedema/etiología , Enfermedad Crónica , Fibrosis , Humanos , Vasos Linfáticos/fisiopatología , Linfedema/patología , Linfedema/fisiopatología
10.
Nutr Diabetes ; 6: e208, 2016 May 02.
Artículo en Inglés | MEDLINE | ID: mdl-27136446

RESUMEN

BACKGROUND: Glucose-dependent insulinotropic polypeptide (GIP) appears to have impaired effect on subcutaneous abdominal adipose tissue metabolism in obese subjects. The aim of the present study was to examine whether weight loss may reverse the impaired effect of GIP on subcutaneous abdominal adipose tissue in obese subjects. METHODS: Five obese males participated in a 12-week weight loss program, which consisted of caloric restriction (800 Cal day(-)(1)) followed by 4 weeks of weight-maintenance diet. Before and after weight loss, subcutaneous adipose tissue lipid metabolism was studied by conducting regional measurements of arterio-venous plasma concentrations of metabolites and blood flow (adipose tissue blood flow, ATBF) across a segment of the abdominal adipose tissue in the fasting state and during GIP infusion (1.5 pmol kg(-)(1 )min(-)(1)) in combination with a hyperinsulinemic-hyperglycemic clamp. RESULTS: After weight loss (7.5±0.8 kg), glucose tolerance and insulin sensitivity increased significantly as expected. No significant differences were seen in basal ATBF before (1.3±0.4 ml min(-1) 100 g tissue(-1)) and after weight loss (2.1±0.4 ml min(-1) 100 g tissue)(-1); however, a tendency to increase was seen. After weight loss, GIP infusion increased ATBF significantly (3.2±0.1 ml min(-1) 100 g tissue(-1)) whereas there was no increase before weight loss. Triacylglycerol (TAG) uptake did not change after weight loss. Baseline free fatty acid (FFA) and glycerol output increased significantly after weight loss, P<0.001. During the clamp period, FFA and glycerol output declined significantly, P<0.05, with no differences before and after weight loss. Weight loss increased glucose uptake and decreased FFA/glycerol ratio during the clamp period, P<0.05. CONCLUSIONS: In obese subjects, weight loss, induced by calorie restriction, improves the blunted effect of GIP on subcutaneous abdominal adipose tissue metabolism.


Asunto(s)
Polipéptido Inhibidor Gástrico/metabolismo , Obesidad/terapia , Grasa Subcutánea Abdominal/metabolismo , Pérdida de Peso , Adulto , Glucemia/metabolismo , Composición Corporal , Índice de Masa Corporal , Restricción Calórica , Dieta , Ayuno , Ácidos Grasos no Esterificados/metabolismo , Humanos , Insulina/sangre , Resistencia a la Insulina , Masculino , Persona de Mediana Edad , Triglicéridos/metabolismo , Programas de Reducción de Peso
11.
Biochim Biophys Acta ; 511(2): 213-23, 1978 Aug 04.
Artículo en Inglés | MEDLINE | ID: mdl-567066

RESUMEN

A regulatory function of the cell membrane in controlling the cytoplasmic level of Pi has been proposed, and in Ehrlich ascites tumor cells an active influx of primary phosphate has been reported in the literature. In the present study, Ehrlich cells were incubated at 1.5--50 mM extracellular Pi at pH 7.4 (Pi mainly secondary phosphate) and at pH 6.0 (mainly primary phosphate), and the measured cell Pi was compared with the value expected from a passive distribution of Pi. At a low extracellular Pi concentration the cell Pi was 3--6 mumol/g or even more. It is suggested that a major part of this cell Pi can be accounted for by enzymic release of Pi during the sampling procedure. If this interpretation is correct, the present results show that both ionic species of Pi are in electrochemical equilibrium across the cell membrane at steady state. Moreover, in vivo the concentration of free Pi in the cytosol will presumably be maintained at a steady-state level of about 0.4 mM, one order of magnitude below the directly measured values. This implies that the ratio [ATP]/[ADP][Pi] which is important in the regulation of energy metabolism, is higher than reported in the literature.


Asunto(s)
Carcinoma de Ehrlich/metabolismo , Membrana Celular/metabolismo , Fosfatos/metabolismo , Animales , Carcinoma de Ehrlich/análisis , Membrana Celular/análisis , Citosol/análisis , Citosol/metabolismo , Fosfatos/análisis
12.
Biochim Biophys Acta ; 692(3): 431-40, 1982 Nov 22.
Artículo en Inglés | MEDLINE | ID: mdl-6293570

RESUMEN

The divalent cation-selective ionophore A23187 has been used to characterize cytoplasmic Ca and Mg buffering, Ca2+-pump parameters and the properties of a Ca2+-activated K+-channel in intact red cells. A critical assumption in these studies has been that the ionophore causes a uniform increase in divalent cation-permeability in all the cells. This has now been tested directly in ATP-depleted human red cells by analysing the kinetics of ionophore-induced 45Ca-tracer and net Ca2+ fluxes. The experimental curves were all adequately fitted by single-exponentials at all ionophore concentrations tested. Moreover, statistical analysis of 61 individual tracer influx curves and of pooled data showed no trend towards fast second exponential components. These results demonstrate uniformity of ionophore distribution, ionophore-induced Ca2+-permeability, and cytoplasmic Ca-buffering among all the cells. Experiments involving mixing of cell suspensions with high and low original ionophore content, and involving ionophore extraction by albumin, demonstrate a rapid redistribution of ionophore among the cells, indicating that homogeneity of ionophoric effects is achieved through dynamic ionophore redistribution.


Asunto(s)
Antibacterianos/sangre , Calcimicina/sangre , Calcio/sangre , Eritrocitos/metabolismo , Transporte Biológico Activo/efectos de los fármacos , Calcimicina/farmacología , Calcio/farmacología , Ácido Egtácico/farmacología , Humanos , Canales Iónicos/metabolismo , Cinética , Matemática , Potasio/sangre
13.
J Pharm Sci ; 94(3): 632-8, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15666298

RESUMEN

In vitro measurements of skin absorption are an increasingly important aspect of regulatory studies, product support claims, and formulation screening. However, such measurements are significantly affected by skin variability. The purpose of this study was to determine inter- and intralaboratory variation in diffusion cell measurements caused by factors other than skin. This was attained through the use of an artificial (silicone rubber) rate-limiting membrane and the provision of materials including a standard penetrant, methyl paraben (MP), and a minimally prescriptive protocol to each of the 18 participating laboratories. "Standardized" calculations of MP flux were determined from the data submitted by each laboratory by applying a predefined mathematical model. This was deemed necessary to eliminate any interlaboratory variation caused by different methods of flux calculations. Average fluxes of MP calculated and reported by each laboratory (60 +/- 27 microg cm(-2) h(-1), n = 25, range 27-101) were in agreement with the standardized calculations of MP flux (60 +/- 21 microg cm(-2) h(-1), range 19-120). The coefficient of variation between laboratories was approximately 35% and was manifest as a fourfold difference between the lowest and highest average flux values and a sixfold difference between the lowest and highest individual flux values. Intralaboratory variation was lower, averaging 10% for five individuals using the same equipment within a single laboratory. Further studies should be performed to clarify the exact components responsible for nonskin-related variability in diffusion cell measurements. It is clear that further developments of in vitro methodologies for measuring skin absorption are required.


Asunto(s)
Técnicas de Laboratorio Clínico/normas , Variaciones Dependientes del Observador , Técnicas de Laboratorio Clínico/estadística & datos numéricos , Difusión , Cámaras de Difusión de Cultivos/métodos , Cámaras de Difusión de Cultivos/normas , Cámaras de Difusión de Cultivos/estadística & datos numéricos , Internacionalidad , Control de Calidad , Estándares de Referencia , Valores de Referencia , Absorción Cutánea/fisiología
14.
Arch Intern Med ; 158(17): 1923-8, 1998 Sep 28.
Artículo en Inglés | MEDLINE | ID: mdl-9759689

RESUMEN

BACKGROUND: A recent study concluded that between 1980 and 1992, deaths from infectious diseases increased 58%. This article explores trends in infectious diseases as a cause of hospitalization. METHODS: We analyzed data from the National Hospitalization Discharge Survey for 1980 through 1994 using a previously developed approach to evaluate infectious diseases in data coded according to the International Classification of Diseases, Ninth Revision. RESULTS: Between 1980 and 1994, the rate of hospitalizations in the United States declined approximately 33%; hospitalizations occurred at a rate of 133+/-5 per 1000 US population (35 million+/-1 million discharges) in 1994. The rate of hospitalization for infectious diseases declined less steeply--12% during this interval--resulting in an increased proportion of hospitalizations because of infectious diseases. In 1994, the rate of hospitalizations for infectious diseases was 15.4+/-0.7 per 1000 US population (4.0 million+/-0.2 million discharges). The fatality rate associated with hospitalizations for infectious diseases increased from 1.9%+/-0.1% to 4.0%+/-0.3%, attributable to increased hospitalizations of elderly persons and an increased fatality rate among those younger than 65 years. Among selected categories, hospitalizations for human immunodeficiency virus infections and acquired immunodeficiency syndrome, prosthetic device infections, sepsis, and mycosis increased substantially, and hospitalizations for upper respiratory tract infections, pelvic inflammatory disease, and oral infections declined sharply. Hospitalizations for lower respiratory tract infections constituted 37% of all infectious disease hospitalizations in 1994. CONCLUSIONS: Considering hospitalizations as a dimension of the burden of infectious diseases involves an array of factors: secular trends in hospitalization, changing case management practices, demographic changes, and trends in the variety of infectious diseases themselves. Increases in the proportions of hospitalizations because of infectious diseases during years when hospitalizations for all causes were decreasing reflect an increasing burden of infectious diseases in the United States between 1989 and the mid-1990s.


Asunto(s)
Enfermedades Transmisibles , Hospitalización/estadística & datos numéricos , Hospitalización/tendencias , Enfermedades Transmisibles/mortalidad , Femenino , Mortalidad Hospitalaria/tendencias , Humanos , Masculino , Estados Unidos/epidemiología
15.
J Acquir Immune Defic Syndr (1988) ; 6(5): 472-7, 1993 May.
Artículo en Inglés | MEDLINE | ID: mdl-8097788

RESUMEN

The objective was to assess the efficacy of a biweekly dose of 60 mg aerosolized pentamidine (AP) for primary prophylaxis (PP) of Pneumocystis carinii pneumonia (PCP) and the impact of prophylaxis on survival in HIV-infected patients. Participants were AIDS patients with no history of PCP, patients with a CD4 count < or = 0.200 x 10(9)/L, or patients belonging to the CDC group IVC2, irrespective of CD4 count. It was an open, randomized, controlled trial. Patients were assigned to receive AP, 60 mg biweekly via a System 22 nebulizer, or to a control group not receiving any prophylaxis. Incidence curves for PCP and survival were generated using the Kaplan-Meier method, stratified by treatment group, and compared using the log-rank test. Data were analyzed according to intention to treat. There were 15 cases of PCP among 105 patients in the AP group and 32 cases among 104 patients in the control group. The cumulative incidence of PCP by 18 months was 13% (95% CI 5-21%) in the AP group and 30% (95% CI 18-41%) in the control group, (p = 0.002). During the study period 19 patients (18%) in the AP group died and 24 patients (23%) in the control group (NS; p = 0.28). We conclude that a biweekly dose of 60 mg AP is efficient as primary PCP prophylaxis when a System 22 nebulizer is used. There was, however, no difference in survival between the groups, suggesting that AP has an impact on morbidity only.


Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/prevención & control , Síndrome de Inmunodeficiencia Adquirida/complicaciones , Pentamidina/administración & dosificación , Neumonía por Pneumocystis/prevención & control , Síndrome de Inmunodeficiencia Adquirida/tratamiento farmacológico , Adulto , Aerosoles , Anciano , Linfocitos T CD4-Positivos , Femenino , Humanos , Recuento de Leucocitos , Masculino , Persona de Mediana Edad , Neumonía por Pneumocystis/complicaciones , Estudios Prospectivos , Análisis de Supervivencia
16.
Eur J Cancer ; 30A(11): 1616-20, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7833132

RESUMEN

The one-carbon unit metabolism was investigated in 8 weight-losing patients with small cell carcinoma of the lung (SCLC). At diagnosis, 6 of the 8 patients had elevated formiminoglutamic acid (FIGLU) excretion after a histidine load, suggesting a lack of one-carbon units. In accordance, a significant decrease of FIGLU excretion was observed in the patients after oral administration of DL-methionine for 4 days. The elevated FIGLU excretion was positively correlated to weight loss prior to diagnosis and negatively correlated to serum albumin at time of diagnosis. After 3 months of combination chemotherapy, FIGLU excretion was reduced in all patients except 1, who had progressive disease. Despite the elevated FIGLU excretions, all patients had normal blood folate levels. The resting energy expenditure (REE) was recorded in 7 patients, and a significant, positive correlation was observed between pretreatment FIGLU excretion and REE, although the REE measured in this group of patients was within the normal range. These data demonstrate an increased demand of "active" one-carbon units in energy consumption in a group of weight-losing cancer patients. The one-carbon unit deficit was reconditioned by oral administration of the one-carbon unit donor DL-methionine.


Asunto(s)
Metabolismo Basal/fisiología , Caquexia/metabolismo , Carbono/metabolismo , Carcinoma de Células Pequeñas/metabolismo , Neoplasias Pulmonares/metabolismo , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Caquexia/etiología , Carcinoma de Células Pequeñas/complicaciones , Carcinoma de Células Pequeñas/tratamiento farmacológico , Femenino , Ácido Formiminoglutámico/orina , Humanos , Neoplasias Pulmonares/complicaciones , Neoplasias Pulmonares/tratamiento farmacológico , Masculino , Metionina/farmacología , Persona de Mediana Edad
17.
Radiat Res ; 133(1): 1-11, 1993 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-8381975

RESUMEN

The GOES-7 time history data of hourly averaged integral proton fluxes at various particle kinetic energies are analyzed for the solar proton event that occurred between October 19 and 29, 1989. By analyzing the time history data, the dose rates which may vary over many orders of magnitude in the early phases of the flare can be estimated as well as the cumulative dose as a function of time. Basic transport calculations are coupled with detailed body organ thickness distributions from computerized anatomical models to estimate dose rates and cumulative doses to 20 critical body organs. For a 5-cm-thick water shield, cumulative skin, eye, and blood-forming-organ dose equivalents of 1.27, 1.23, and 0.41 Sv, respectively, are estimated. These results are approximately 40-50% less than the widely used 0- and 5-cm slab dose estimates. The risk of cancer incidence and mortality are also estimated for astronauts protected by various water shield thicknesses.


Asunto(s)
Neoplasias Inducidas por Radiación/etiología , Protones , Vuelo Espacial , Luz Solar , Humanos , Modelos Anatómicos , Dosis de Radiación , Riesgo , Factores de Tiempo
18.
J Appl Physiol (1985) ; 87(1): 111-5, 1999 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10409564

RESUMEN

The present study compared the arteriohepatic venous (a-hv) balance technique and the tracer-dilution method for estimation of hepatic glucose production during both moderate and heavy exercise in humans. Eight healthy young men (aged 25 yr; range, 23-30 yr) performed semisupine cycling for 40 min at 50.4 +/- 1.5(SE)% maximal O(2) consumption, followed by 30 min at 69.0 +/- 2.2% maximal O(2) consumption. The splanchnic blood flow was estimated by continuous infusion of indocyanine green, and net splanchnic glucose output was calculated as the product of splanchnic blood flow and a-hv blood glucose concentration differences. Glucose appearance rate was determined by a primed, continuous infusion of [3-(3)H]glucose and was calculated by using formulas for a modified single compartment in non-steady state. Glucose production was similar whether determined by the a-hv balance technique or by the tracer-dilution method, both at rest and during moderate and intense exercise (P > 0. 05). It is concluded that, during exercise in humans, determination of hepatic glucose production can be performed equally well with the two techniques.


Asunto(s)
Ejercicio Físico/fisiología , Glucosa/biosíntesis , Adulto , Colorantes , Estudios de Evaluación como Asunto , Humanos , Verde de Indocianina , Hígado/metabolismo , Masculino , Consumo de Oxígeno , Circulación Esplácnica , Tritio
19.
J Appl Physiol (1985) ; 89(5): 1868-78, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11053338

RESUMEN

Using near-infrared spectroscopy (NIRS) and the tracer indocyanine green (ICG), we quantified blood flow in calf muscle and around the Achilles tendon during plantar flexion (1-9 W). For comparison, blood flow in calf muscle was determined by dye dilution in combination with magnetic resonance imaging measures of muscle volume, and, for the peritendon region, blood flow was measured by (133)Xe washout. From rest to a peak load of 9 W, NIRS-ICG blood flow in calf muscle increased from 2.4+/-0.2 to 74+/-5 ml x 100 ml tissue(-1) x min(-1), similar to that measured by reverse dye (77+/-6 ml x 100 ml tissue(-1) x min(-1)). Achilles peritendon blood flow measured by NIRS-ICG rose with exercise from 2.2+/-0.5 to 15.1+/-0.2 ml x 100 ml(-1) x min(-1), which was similar to that determined by (133)Xe washout (2.0+/-0.6 to 14.6+/-0.3 ml x 100 ml tissue(-1) x min(-1)). This is the first study using NIRS and ICG to quantify regional tissue blood flow during exercise in humans. Due to its high spatial and temporal resolution, the technique may be useful for determining regional blood flow distribution and regulation during exercise in humans.


Asunto(s)
Colorantes , Ejercicio Físico/fisiología , Verde de Indocianina , Flujo Sanguíneo Regional/fisiología , Espectroscopía Infrarroja Corta/métodos , Humanos , Pierna/irrigación sanguínea , Pierna/fisiología , Músculo Esquelético/irrigación sanguínea , Músculo Esquelético/fisiología , Sensibilidad y Especificidad , Radioisótopos de Xenón
20.
J Neurosci Methods ; 34(1-3): 187-92, 1990 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-2259241

RESUMEN

Ingestion of carbohydrate results in a diphasic activation of the sympathoadrenal system. One component is an insulin-mediated activation of the sympathetic nervous system (SNS). This activation is partly a haemodynamic reflex, but it may cause a weak thermogenic effect via beta 1-adrenoceptors in white adipose tissue, the liver and the heart. The second thermogenic component of carbohydrate occurs later when the blood glucose concentration decreases towards baseline levels. This elicits an increased secretion of adrenaline from the adrenal medulla, and the circulating level exceeds the physiological threshold for thermogenic effect. The target is mainly skeletal muscle where thermogenesis is stimulated via beta 2-adrenoceptors. Also the basal metabolic rate and the thermogenic responses to cold and heat exposure, mental stress and exercise, have facultative components. Inhibition of facultative thermogenesis by beta-blockers such as propranolol, diminishes the daily energy expenditure and promotes weight gain and obesity. Although thermogenesis mediated by the sympathoadrenal system accounts for only a small part of the daily energy expenditure, it is sufficient to explain the positive energy balance and weight gain reported in patients receiving treatment with beta-adrenoceptor blocking agents.


Asunto(s)
Glándulas Suprarrenales/fisiología , Regulación de la Temperatura Corporal/fisiología , Fenómenos Fisiológicos de la Nutrición , Sistema Nervioso Simpático/fisiología , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA